Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Daily
21m
FDA approves Semaglutide for renal protection among diabetes patients with CKD
Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...
25m
on MSN
Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
42m
on MSN
Sam Altman's India visit next week: why it is significant
OpenAI was openly challenged by Chinese startup DeepSeek in the AI arena, which the ChatGPT maker has commanded since 2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Crash at Reagan airport
Los Angeles wildfire updates
FDA upgrades recall
Gets 11 years in prison
OK school citizenship rule
Lay's potato chips recall
Denver schools face probe
CO military base for ICE use
Signs Laken Riley Act
Security detail revoked
ICC sanctions bill blocked
Approved for kidney disease
1st Latina, Black AZ justice
To lay off 234 workers
Hush money conviction appeal
NC inmate escapes
'The Voice' alum dies at 44
Senate confirmation hearing
Email privacy lawsuit filed
Recalls chicken nuggets
Cutting corporate workforce
Fall behind in reading
Agrees to settle Trump suit
Record trade deficit in goods
Drops classified docs case
To recall 290K+ vehicles
To hold migrants
Pushes for earlier trial
OpenAI probing DeepSeek
Rescinds freeze on grants
Related topics
Ozempic
Novo Nordisk
Wegovy
thyroid cancer
Eli Lilly
Feedback